The Effects of Bromelain Supplement in Patients With Ulcerative Colitis

Launched by NATIONAL NUTRITION AND FOOD TECHNOLOGY INSTITUTE · Apr 5, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a natural supplement called bromelain in patients with mild to moderate ulcerative colitis (UC), a condition that causes inflammation in the digestive tract. Some participants may also have primary sclerosing cholangitis (PSC), a liver condition. The study will last for 8 weeks, during which participants will follow a low FODMAP diet and be randomly assigned to either receive bromelain or a placebo (a non-active substance that looks like the real treatment). Researchers will measure different health indicators before and after the study to see how effective the bromelain is.

To be eligible for this trial, participants should be between 18 and 75 years old and have active mild to moderate UC. They cannot have other chronic health issues or have recently changed their medications. Participants can expect regular check-ins and assessments during the study, and they should be committed to following the study guidelines. This trial is currently recruiting, and it's a great opportunity for those looking to explore new treatment options for their condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • active mild to moderate UC
• • no other chronic disorders
• Exclusion Criteria:
• • changed the type and dosage of their medication in the last month
• • those who have relapses that required hospitalization and change the type and dosage of medications during the intervention
• • patients who do not want to continue the study protocol